<SEC-DOCUMENT>0001144204-19-029712.txt : 20190604
<SEC-HEADER>0001144204-19-029712.hdr.sgml : 20190604
<ACCEPTANCE-DATETIME>20190604160143
ACCESSION NUMBER:		0001144204-19-029712
CONFORMED SUBMISSION TYPE:	8-K
PUBLIC DOCUMENT COUNT:		3
CONFORMED PERIOD OF REPORT:	20190531
ITEM INFORMATION:		Other Events
ITEM INFORMATION:		Financial Statements and Exhibits
FILED AS OF DATE:		20190604
DATE AS OF CHANGE:		20190604

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			Apollo Medical Holdings, Inc.
		CENTRAL INDEX KEY:			0001083446
		STANDARD INDUSTRIAL CLASSIFICATION:	SERVICES-MANAGEMENT CONSULTING SERVICES [8742]
		IRS NUMBER:				870042699
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		8-K
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	001-37392
		FILM NUMBER:		19876587

	BUSINESS ADDRESS:	
		STREET 1:		1668 S. GARFIELD AVENUE
		STREET 2:		2ND FLOOR
		CITY:			ALHAMBRA
		STATE:			CA
		ZIP:			91801
		BUSINESS PHONE:		(626) 282-0288

	MAIL ADDRESS:	
		STREET 1:		1668 S. GARFIELD AVENUE
		STREET 2:		2ND FLOOR
		CITY:			ALHAMBRA
		STATE:			CA
		ZIP:			91801

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	SICLONE INDUSTRIES INC
		DATE OF NAME CHANGE:	19990413
</SEC-HEADER>
<DOCUMENT>
<TYPE>8-K
<SEQUENCE>1
<FILENAME>tv523071_8k.htm
<DESCRIPTION>FORM 8-K
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="margin: 0"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>



<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"></P>

<!-- Field: Rule-Page --><DIV ALIGN="LEFT" STYLE="margin-top: 12pt; margin-bottom: 3pt"><DIV STYLE="font-size: 1pt; border-top: Black 2pt solid; border-bottom: Black 1pt solid; width: 100%">&nbsp;</DIV></DIV><!-- Field: /Rule-Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"></P>

<P STYLE="font: 18pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>UNITED STATES</B></P>

<P STYLE="font: 18pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>SECURITIES AND EXCHANGE COMMISSION</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>WASHINGTON, DC 20549</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"></P>

<!-- Field: Rule-Page --><DIV ALIGN="LEFT" STYLE="margin-top: 3pt; margin-bottom: 3pt"><DIV STYLE="font-size: 1pt; border-top: Black 1pt solid; width: 100%">&nbsp;</DIV></DIV><!-- Field: /Rule-Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 18pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>FORM 8-K</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<!-- Field: Rule-Page --><DIV ALIGN="LEFT" STYLE="margin-top: 3pt; margin-bottom: 3pt"><DIV STYLE="font-size: 1pt; border-top: Black 1pt solid; width: 100%">&nbsp;</DIV></DIV><!-- Field: /Rule-Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>CURRENT REPORT</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>Pursuant to Section&nbsp;13 or 15(d)
of the</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>Securities Exchange Act of 1934</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>Date of report (Date of earliest event
reported): </B>June 4, 2019 (May 31, 2019)</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;&nbsp;</P>

<!-- Field: Rule-Page --><DIV ALIGN="LEFT" STYLE="margin-top: 3pt; margin-bottom: 3pt"><DIV STYLE="font-size: 1pt; border-top: Black 1pt solid; width: 100%">&nbsp;</DIV></DIV><!-- Field: /Rule-Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 18pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>APOLLO MEDICAL HOLDINGS, INC.</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>(Exact Name of Registrant as Specified
in Charter)</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<!-- Field: Rule-Page --><DIV ALIGN="LEFT" STYLE="margin-top: 3pt; margin-bottom: 3pt"><DIV STYLE="font-size: 1pt; border-top: Black 1pt solid; width: 100%">&nbsp;</DIV></DIV><!-- Field: /Rule-Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<TR STYLE="vertical-align: bottom">
    <TD STYLE="width: 32%; font-size: 10pt; text-align: center"><FONT STYLE="font-size: 10pt">Delaware</FONT></TD>
    <TD STYLE="width: 2%; font-size: 10pt">&nbsp;</TD>
    <TD STYLE="width: 32%; font-size: 10pt; text-align: center"><FONT STYLE="font-size: 10pt">001-37392</FONT></TD>
    <TD STYLE="width: 2%; font-size: 10pt">&nbsp;</TD>
    <TD STYLE="width: 32%; font-size: 10pt; text-align: center"><FONT STYLE="font-size: 10pt">95-4472349</FONT></TD></TR>
<TR STYLE="vertical-align: bottom">
    <TD>
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>(State or Other Jurisdiction</B></P>
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>of Incorporation)</B></P></TD>
    <TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD>
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>(Commission</B></P>
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>File Number)</B></P></TD>
    <TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD>
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>(I.R.S. Employer</B></P>
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>Identification No.)</B></P></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">1668 S. Garfield Avenue, 2nd Floor, Alhambra,
CA 91801</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>(Address of Principal Executive Offices,
and Zip Code)</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">(626) 282-0288</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>Registrant&rsquo;s Telephone Number,
Including Area Code</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>&nbsp;</B></P>

<TABLE CELLSPACING="0" CELLPADDING="0" ALIGN="CENTER" STYLE="font: 10pt Times New Roman, Times, Serif; width: 60%; border-collapse: collapse">
<TR STYLE="vertical-align: bottom">
    <TD STYLE="border-bottom: black 1pt solid; font-size: 10pt; text-align: center; width: 60%">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom">
    <TD STYLE="white-space: nowrap; font-size: 10pt; text-align: center"><FONT STYLE="font-size: 10pt"><B>(Former Name or Former Address, if Changed Since Last Report)</B></FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Check the appropriate box below if the Form 8-K filing is intended
to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (<I>see</I> General Instruction
A.2. below):</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<TR>
    <TD STYLE="width: 3%; font-size: 10pt">&nbsp;</TD>
    <TD STYLE="vertical-align: top; width: 3%; font-size: 10pt"><FONT STYLE="font-family: Wingdings; font-size: 10pt">&uml;</FONT></TD>
    <TD STYLE="vertical-align: top; width: 94%; font-size: 10pt"><FONT STYLE="font-size: 10pt">Written communication pursuant to Rule 425 under the Securities Act (17 CFR 230.425)</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<TR>
    <TD STYLE="width: 3%">&nbsp;</TD>
    <TD STYLE="vertical-align: top; width: 3%"><FONT STYLE="font-family: Wingdings; font-size: 10pt">&uml;</FONT></TD>
    <TD STYLE="vertical-align: top; width: 94%"><FONT STYLE="font-size: 10pt">Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<TR>
    <TD STYLE="width: 3%">&nbsp;</TD>
    <TD STYLE="vertical-align: top; width: 3%"><FONT STYLE="font-family: Wingdings; font-size: 10pt">&uml;</FONT></TD>
    <TD STYLE="vertical-align: top; width: 94%"><FONT STYLE="font-size: 10pt">Pre-commencement communication pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<TR STYLE="vertical-align: top">
    <TD STYLE="width: 3%">&nbsp;</TD>
    <TD STYLE="width: 3%"><FONT STYLE="font-family: Wingdings; font-size: 10pt">&uml;</FONT></TD>
    <TD STYLE="width: 94%; text-align: justify"><FONT STYLE="font-size: 10pt">Pre-commencement communication pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Securities registered pursuant to Section 12(b) of the Act:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<TR STYLE="vertical-align: top">
    <TD STYLE="width: 41%; border: black 1pt solid; padding-right: 5.4pt; padding-bottom: 2.2pt; padding-left: 5.4pt; text-align: center"><FONT STYLE="font-size: 10pt">Title of each class</FONT></TD>
    <TD STYLE="width: 23%; border-top: black 1pt solid; border-right: black 1pt solid; border-bottom: black 1pt solid; padding-right: 5.4pt; padding-bottom: 2.2pt; padding-left: 5.4pt; text-align: center"><FONT STYLE="font-size: 10pt">Trading Symbol(s)</FONT></TD>
    <TD STYLE="width: 36%; border-top: black 1pt solid; border-right: black 1pt solid; border-bottom: black 1pt solid; padding-right: 5.4pt; padding-bottom: 2.2pt; padding-left: 5.4pt; text-align: center"><FONT STYLE="font-size: 10pt">Name of each exchange on which registered</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="border-right: black 1pt solid; border-bottom: black 1pt solid; border-left: black 1pt solid; padding-right: 5.4pt; padding-bottom: 2.2pt; padding-left: 5.4pt; text-align: center"><FONT STYLE="font-size: 10pt">Common Stock</FONT></TD>
    <TD STYLE="border-bottom: black 1pt solid; border-right: black 1pt solid; padding-right: 5.4pt; padding-bottom: 2.2pt; padding-left: 5.4pt; text-align: center"><FONT STYLE="font-size: 10pt">AMEH</FONT></TD>
    <TD STYLE="border-bottom: black 1pt solid; border-right: black 1pt solid; padding-right: 5.4pt; padding-bottom: 2.2pt; padding-left: 5.4pt; text-align: center"><FONT STYLE="font-size: 10pt">Nasdaq Capital Market</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; background-color: white">Indicate by check mark whether the
registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (17 CFR &sect;230.405) or Rule 12b-2
of the Securities Exchange Act of 1934 (17 CFR &sect;240.12b-2).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: right; background-color: white">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; background-color: white">Emerging growth company <FONT STYLE="font-family: Wingdings">&uml;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">If an emerging growth company, indicate by check mark if the
registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards
provided pursuant to Section 13(a) of the Exchange Act. <FONT STYLE="font-family: Wingdings">&uml;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;&nbsp;</P>

<!-- Field: Rule-Page --><DIV ALIGN="LEFT" STYLE="margin-top: 3pt; margin-bottom: 12pt"><DIV STYLE="font-size: 1pt; border-top: Black 1pt solid; border-bottom: Black 2pt solid; width: 100%">&nbsp;</DIV></DIV><!-- Field: /Rule-Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>


<!-- Field: Page; Sequence: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: right">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>Item 8.01 Other Events.</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">On June 4, 2019, Apollo Medical Holdings,
Inc. (the &ldquo;Company&rdquo;), an integrated population health management company, issued a press release announcing that Allied
Physicians of California, a Professional Medical Corporation d.b.a. Allied Pacific of California (&ldquo;APC&rdquo;), and APC-LSMA
Designated Shareholder Medical Corporation (&ldquo;APC-LSMA&rdquo;), have completed their acquisition of Alpha Care Medical Group,
Inc. (&ldquo;Alpha Care&rdquo;). Under the terms of the stock purchase agreement (&ldquo;SPA&rdquo;) APC and APC-LSMA acquired
100% of the capital stock of Alpha Care from Dr. Kevin Tyson for an aggregate purchase price of $45,000,000 in cash, subject to
post-closing adjustments, as defined under the SPA.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">A copy of the press release is attached
as Exhibit 99.1 to this Current Report on Form 8-K and is incorporated herein by reference.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>Item 9.01&nbsp;&nbsp;&nbsp;&nbsp;Financial
Statements and Exhibits</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">(d) Exhibits.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<TR STYLE="vertical-align: top">
    <TD STYLE="width: 5%; padding-left: 0.5in; text-indent: -0.5in"><A HREF="tv523071_ex99-1.htm" STYLE="-sec-extract: exhibit"><FONT STYLE="font-size: 10pt">99.1 -</FONT></A></TD>
    <TD STYLE="text-indent: 13.4pt; width: 2%">&nbsp;</TD>
    <TD STYLE="width: 93%"><A HREF="tv523071_ex99-1.htm" STYLE="-sec-extract: exhibit"><FONT STYLE="font-size: 10pt">Press Release of Apollo Medical Holdings, Inc., dated June 4, 2019.</FONT></A></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"></P>

<!-- Field: Page; Sequence: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>SIGNATURES</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">Pursuant to the requirements of the Securities
and Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly
authorized.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
<TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD COLSPAN="2"><FONT STYLE="font-size: 10pt"><B>APOLLO MEDICAL HOLDINGS, INC.</B></FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD COLSPAN="2">&nbsp;</TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="width: 48%"><FONT STYLE="font-size: 10pt">Dated: June 4, 2019</FONT></TD>
    <TD STYLE="width: 5%"><FONT STYLE="font-size: 10pt">By:&nbsp;</FONT></TD>
    <TD STYLE="width: 47%; border-bottom: black 1pt solid"><FONT STYLE="font-size: 10pt"><I>/s/ Thomas S. Lam, M.D</I></FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD STYLE="white-space: nowrap"><FONT STYLE="font-size: 10pt">Name: </FONT></TD>
    <TD><FONT STYLE="font-size: 10pt">Thomas S. Lam, M.D</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD><FONT STYLE="font-size: 10pt">Title:&nbsp;&nbsp;&nbsp;&nbsp; </FONT></TD>
    <TD><FONT STYLE="font-size: 10pt">Chief Executive Officer</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>



<P STYLE="margin: 0"></P>

<!-- Field: Page; Sequence: 3; Options: Last -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="margin: 0"></P>

</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-99.1
<SEQUENCE>2
<FILENAME>tv523071_ex99-1.htm
<DESCRIPTION>EXHIBIT 99.1
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="margin: 0; text-align: right"><B>Exhibit 99.1</B></P>

<P STYLE="margin: 0; text-align: right"></P>

<P STYLE="margin-top: 0; margin-bottom: 0; text-align: center">&nbsp;<IMG SRC="logo.jpg" ALT=""></P>

<P STYLE="margin-top: 0; margin-bottom: 0; text-align: center"></P>

<P STYLE="margin-top: 0; margin-bottom: 0; text-align: left"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp; <B>APOLLO MEDICAL HOLDINGS ANNOUNCES
ACQUISITION OF ALPHA CARE MEDICAL GROUP</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B><I>Alhambra, CA &ndash; (PR Newswire)
 &ndash; June 4, 2019 &ndash;</I></B> Apollo Medical Holdings, Inc. (&ldquo;ApolloMed&rdquo; or the &ldquo;Company&rdquo;) (NASDAQ:
AMEH), an integrated population health management company, today announced that Allied Physicians of California, a Professional
Medical Corporation d.b.a. Allied Pacific of California (&ldquo;APC&rdquo;) and APC-LSMA Designated Shareholder Medical Corporation
(&ldquo;APC-LSMA&rdquo;) have completed their acquisition of Alpha Care Medical Group, Inc. (&ldquo;Alpha Care&rdquo;). APC&nbsp;is
an independent practice association (&ldquo;IPA&rdquo;) that the Company has determined should be consolidated as a variable interest
entity (&ldquo;VIE&rdquo;) with the Company&rsquo;s financial statements under United States generally accepted accounting principles
(U.S. GAAP). APC-LSMA has as its sole shareholder, Thomas Lam, M.D., Chief Executive Officer of the Company and Chief Executive
and Financial Officer of APC, and is controlled by APC.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">On May 31, 2019, under the terms of the
stock purchase agreement, APC and APC-LSMA acquired 100% of the capital stock of Alpha Care from Dr. Kevin Tyson for an aggregate
purchase price of $45,000,000 in cash, subject to post-closing adjustments, as defined.&nbsp; The completion of this acquisition
will expand the Company&rsquo;s capitated membership population base and deepen its geographic footprint in Southern California.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Alpha Care, an IPA which has been operating
in California since 1993, is a risk bearing organization engaged in providing professional services under capitation arrangements
with its contracted health plans through a provider network consisting of primary care and specialty care physicians. Alpha Care
specializes in delivering high-quality healthcare to over 180,000 enrollees and focuses on Medi-Cal/Medicaid, Commercial, and Medicare
and Dual Eligible members in the Riverside and San Bernardino counties of Southern California.</P>



<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&ldquo;The acquisition of Alpha Care positions
our patient-centered, physician-led organization to replicate our business model in the Riverside and San Bernardino counties,
while realizing the synergies of aggregating multiple IPAs,&rdquo; said Kenneth Sim, M.D., Executive Chairman of ApolloMed. &ldquo;This
acquisition demonstrates our continued commitment to the growth of our company,&rdquo; stated Dr. Kenneth Sim.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>


<!-- Field: Page; Sequence: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp; <B>&nbsp;&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>Note About Consolidated Entities</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">The Company consolidates
entities in which it has a controlling financial interest. The Company consolidates subsidiaries in which it holds, directly or
indirectly, more than 50% of the voting rights, and variable interest entities (&ldquo;VIEs&rdquo;) in which the Company is the
primary beneficiary. Noncontrolling interests represent equity ownership interests in the Company&rsquo;s consolidated entities
(including certain VIEs). The amount of net (loss) income attributable to noncontrolling interests is disclosed in the Company&rsquo;s
consolidated statements of income.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; color: #333333">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>About Apollo Medical Holdings, Inc.</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; background-color: white">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">ApolloMed is a
leading physician-centric integrated population health management company, which, together with its subsidiaries, including a Next
Generation Accountable Care Organization (&ldquo;NGACO&rdquo;), and its affiliated independent practice associations (&ldquo;IPAs&rdquo;)
and management services organizations (&ldquo;MSOs&rdquo;), are working to provide coordinated, outcomes-based high-quality medical
care for patients, particularly senior patients and patients with multiple chronic conditions, in a cost-effective manner.&nbsp;
ApolloMed focuses on addressing the healthcare needs of its patients by leveraging its integrated health management and healthcare
delivery platform that includes Network Medical Management, Inc. (an MSO), Apollo Medical Management, Inc. (an MSO), ApolloMed
Hospitalists,&nbsp;APA ACO, Inc. (the Company&rsquo;s NGACO), APC (an IPA) and Apollo Care Connect, Inc. (the Company&rsquo;s Digital
Population Health Management Platform).&nbsp; For more information, please visit&nbsp;www.apollomed.net.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>


<!-- Field: Page; Sequence: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>Forward Looking Statements</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><I>This press
release contains forward-looking statements&nbsp;within the meaning of the Private Securities Litigation Reform Act of 1995, Section
27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended, such as statements
about the Company&rsquo;s continued growth and business outlook, ability to deliver sustainable long-term value, ability to respond
to the changing environment, operational focus and strategic growth plans as well as the impact of the Company&rsquo;s acquisitions.&nbsp;Forward-looking
statements reflect current views with respect to future events and financial performance and therefore cannot be guaranteed.&nbsp;Such
statements are based&nbsp;on&nbsp;the current expectations and certain assumptions of the Company's management, and some or all
of such expectations and assumptions may not materialize or may vary significantly from actual results.&nbsp;Actual results may
also vary materially from forward-looking statements due to risks, uncertainties and other factors, known and unknown, including
the risk factors described from time to time in the Company's reports to the SEC, including, without limitation, the risk factors
discussed in the&nbsp;Company's Annual Report on Form 10-K filed with the SEC on&nbsp;March 18, 2019.</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; color: #333333">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>FOR MORE INFORMATION, PLEASE CONTACT<FONT STYLE="color: #4D4D4D">:</FONT></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>Eric Chin</B><BR>
Chief Financial Officer<BR>
Apollo Medical Holdings, Inc.<BR>
(626) 943-6008<BR>
<U>Eric.Chin@nmm.cc</U></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<!-- Field: Page; Sequence: 3; Options: Last -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>



<P STYLE="margin-top: 0; margin-bottom: 0; text-align: left"></P>

</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>3
<FILENAME>logo.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 logo.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  @&!@<&!0@'!P<)"0@*#!0-# L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+# Q-#0T'R<Y/3@R/"XS-#+_
MVP!# 0D)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P  1" !U 5(# 2(  A$! Q$!_\0
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
>HHHH **** "BBB@ HHHH **** "BBB@ HHHH __9

end
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
